There was also no impact of 5-OP-RU administration on the magnitude of Mtb-specific CD4 and CD8 T cells in the blood, spleen, LNs, granulomas or instillation site lesions at necropsy (Fig. 5e, f). This evidence concerns the gene CD8A and Granuloma.